These findings were further supported by similar results obtained in the GSE31684 cohort (Supplementary Figure 3), which confirmed that EPHB6 may contribute to the development of a cold immune microenvironment in BLCA. Here, EPHB6 is linked to bladder transitional cell carcinoma.